Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Murali Mohan Reddy, Jackson Dhas Devavaram, Jebasingh Dhas, Ernest Adeghate & Bright Starling Emerald. (2015) Anti-hyperlipidemic effect of methanol bark extract of Terminalia chebula in male albino Wistar rats. Pharmaceutical Biology 53:8, pages 1133-1140.
Read now
Read now
Articles from other publishers (22)
Melissa Soohoo, Leila Hashemi, Jui‐Ting Hsiung, Hamid Moradi, Matthew J. Budoff, Csaba P. Kovesdy, Kamyar Kalantar‐Zadeh & Elani Streja. (2021) Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans. Journal of the American Heart Association 10:23.
Crossref
Crossref
Shan Zheng, Wenzhi Zhu, Qin Shi, Minzhen Wang, Yonghong Nie, Desheng Zhang, Zhiyuan Cheng, Chun Yin, Qian Miao, Yan Luo & Yana Bai. (2021) Effects of cold and hot temperature on metabolic indicators in adults from a prospective cohort study. Science of The Total Environment 772, pages 145046.
Crossref
Crossref
John B. Whitfield, Lucía Colodro-Conde, Paul R. H. J. Timmers, Peter K. Joshi, Grant W. Montgomery & Nicholas G. Martin. (2021) Comparison of Familial, Polygenic and Biochemical Predictors of Mortality. Twin Research and Human Genetics 23:6, pages 307-315.
Crossref
Crossref
A. J. Cupido, R. M. Stoekenbroek & J. J. P. Kastelein. 2020. Clinical Cardiogenetics. Clinical Cardiogenetics
387
411
.
Tian-li Xia, Yi-ming Li, Fang-yang Huang, Hua Chai, Bao-tao Huang, Qiao Li, Zhen-gang Zhao, Yan-biao Liao, Zhi-liang Zuo, Yong Peng, Mao Chen & De-jia Huang. (2019) The triglyceride paradox in the mortality of coronary artery disease. Lipids in Health and Disease 18:1.
Crossref
Crossref
Melissa Soohoo, Hamid Moradi, Yoshitsugu Obi, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh & Elani Streja. (2019) Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans. Journal of Clinical Lipidology 13:5, pages 744-753.e15.
Crossref
Crossref
Peter P. Toth. 2019. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting
39
69
.
Hye-Ryoung Kim & Hee-Seung Kim. (2017) Autonomy-supportive, Web-based lifestyle modification for cardiometabolic risk in postmenopausal women: Randomized trial. Nursing & Health Sciences 19:4, pages 509-517.
Crossref
Crossref
D. Martini, S. Rossi, B. Biasini, I. Zavaroni, G. Bedogni, M. Musci, C. Pruneti, G. Passeri, M. Ventura, S. Di Nuzzo, D. Galli, P. Mirandola, M. Vitale, A. Dei Cas, R.C. Bonadonna & D. Del Rio. (2017) Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. Nutrition, Metabolism and Cardiovascular Diseases 27:6, pages 473-503.
Crossref
Crossref
Paulo Ricardo Nazário Viecili, Brenda da Silva, Gabriela E. Hirsch, Fernando G. Porto, Mariana M. Parisi, Alison R. Castanho, Michele Wender & Jonatas Z. Klafke. 2017.
1
44
.
Péter Koncsos, Péter Fülöp, Imre Juhász, Klára Bíró, László Márk, Gábor Simonyi & György Paragh. (2016) Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome. Wiener klinische Wochenschrift 128:23-24, pages 858-863.
Crossref
Crossref
Alan J. Mouton, John K. Maxi, Flavia Souza-Smith, Gregory J. Bagby, Nicholas W. Gilpin, Patricia E. Molina & Jason D. Gardner. (2016) Alcohol Vapor Inhalation as a Model of Alcohol-Induced Organ Disease. Alcoholism: Clinical and Experimental Research 40:8, pages 1671-1678.
Crossref
Crossref
Leonardo Calza, Vincenzo Colangeli, Roberto Manfredi, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2016) Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients. Journal of Antimicrobial Chemotherapy 71:6, pages 1451-1465.
Crossref
Crossref
Karam I. Turk-Adawi, Neil B. Oldridge, Mark J. Vitcenda, Sergey S. Tarima & Sherry L. Grace. (2016) Secondary Prevention Recommendation Attainment with Cardiac Rehabilitation: Is There a Gender Disparity?. Women's Health Issues 26:3, pages 278-287.
Crossref
Crossref
Carl D. Reimers & Guido Knapp. 2016. Prävention und Therapie durch Sport, Band 4. Prävention und Therapie durch Sport, Band 4
29
92
.
A. J. Cupido, R. M. Stoekenbroek & J. J. P. Kastelein. 2016. Clinical Cardiogenetics. Clinical Cardiogenetics
331
354
.
Henry J. Henk, Carly J. Paoli & Shravanthi R. Gandra. (2015) A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia. Advances in Therapy 32:11, pages 1104-1116.
Crossref
Crossref
Richard Kones & Umme Rumana. (2015) Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs 75:11, pages 1201-1228.
Crossref
Crossref
Claudia Stefanutti & Ulrich Julius. (2015) Treatment of primary hypertriglyceridemia states – General approach and the role of extracorporeal methods. Atherosclerosis Supplements 18, pages 85-94.
Crossref
Crossref
Sanjay Chatterjee, Anirban Majumder & Subir Ray. (2015) Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes. Scientific Reports 5:1.
Crossref
Crossref
Werner Kramer. 2016. Metabolic Control. Metabolic Control
373
435
.
Jesús Millán Núñez-Cortés, Juan Pedro-Botet Montoya & Xavier Pintó Sala. (2014) Dislipidemia aterogénica y riesgo residual. Estado de la cuestión en 2014. Clínica e Investigación en Arteriosclerosis 26:6, pages 287-292.
Crossref
Crossref